Sartans Recalled In UK As Further Impurity Is Confirmed
Follows 2018 Europe-Wide Nitrosamines Crisis
Executive Summary
Certain batches of two angiotensin II receptor blockers, or sartans, are being recalled in the UK after an impurity that can potentially increase the risk of cancer over time was detected.